CARBIDOPA, LEVODOPA AND ENTACAPONE 18.75 mg/1

Carbidopa, Levodopa, and Entacapone 18.75 mg/1 is a combination medication used to manage symptoms of Parkinson's disease. This oral tablet helps improve movement and reduce tremors by increasing dopamine levels in the brain.

Carbidopa, Levodopa, and Entacapone 18.75 mg/1 is primarily used to treat Parkinson's disease. It works by replenishing dopamine, a chemical in the brain that is depleted in Parkinson's patients. This medication is often prescribed to alleviate symptoms such as stiffness, tremors, and difficulty with walking and coordination. It is also used to manage the fluctuations in symptoms that can occur as the disease progresses.

Common effects of Carbidopa, Levodopa, and Entacapone 18.75 mg/1 may include nausea, dizziness, and headache. Some users might experience involuntary movements, insomnia, or changes in appetite. These effects can vary in intensity and may diminish over time as the body adjusts to the medication.

Carbidopa, Levodopa, and Entacapone 18.75 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may cause drowsiness or dizziness, so it is advisable to avoid driving or operating heavy machinery until you know how it affects you.

Carbidopa, Levodopa, and Entacapone 18.75 mg/1 may interact with certain medications, including other Parkinson's drugs, antidepressants, and blood pressure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it can exacerbate side effects.